Organophosphate-induced brain injuries: delayed apoptosis mediated by nitric oxide

Y B Kim1, G H Hur, S Shin

  • 1Biomedical Assessment Laboratory (1-3-4), Agency for Defense Development, Yuseong P.O. Box 35-1, Taejon 305-600, South Korea.

Insights

Organophosphate poisoning causes brain injuries, including seizures and cell death. Nitric oxide may play a role in the delayed apoptotic brain injury following organophosphate exposure.

Area of Science:

  • Neuroscience
  • Toxicology
  • Cell Biology

Background:

  • Organophosphate compounds are widely used, but their neurotoxic effects are a significant concern.
  • Understanding the mechanisms of organophosphate-induced brain injury is crucial for developing effective treatments.

Purpose of the Study:

  • To investigate the characteristics of brain injuries induced by organophosphate poisoning.
  • To explore the potential role of nitric oxide in the pathogenesis of these injuries.

Main Methods:

  • Rats were poisoned with diisopropylfluorophosphate (an organophosphate) and treated with protective agents.
  • Brain injuries were assessed for necrotic and apoptotic cell death at various time points.
  • Cerebrospinal fluid nitrite/nitrate levels were measured.
  • The effect of a nitric oxide synthase inhibitor on brain injury and seizures was evaluated.

Main Results:

  • Diisopropylfluorophosphate induced limbic seizures, early necrotic brain injury (maximal at 1h), and delayed apoptotic brain injury (starting at 12h).
  • Necrotic injury was prominent in the hippocampus and piriform/entorhinal cortices.
  • Apoptotic cells appeared in the thalamus and amygdala.
  • Nitrite/nitrate levels increased significantly after poisoning.
  • Inhibiting nitric oxide synthase reduced nitrite/nitrate levels and attenuated apoptotic injury, but not seizure intensity or necrotic injury.

Conclusions:

  • Organophosphate poisoning causes distinct patterns of necrotic and apoptotic brain injury.
  • Delayed apoptotic brain injury following organophosphate exposure may be partly mediated by nitric oxide production.

Related Concept Videos

Anticholinesterase Agents: Poisoning and Treatment01:26

Anticholinesterase Agents: Poisoning and Treatment

Anticholinesterases, also known as cholinesterase inhibitors, work by blocking the breakdown of acetylcholine, leading to its accumulation in the synaptic cleft. This accumulation indirectly enhances both muscarinic and nicotinic actions. These agents are classified as reversible or irreversible based on their mechanism of action.     
Irreversible agents form a strong bond with the cholinesterase enzyme, making it inactive. The breakdown of the phosphorylated enzyme is slower than the...
Nitric Oxide Signaling Pathway01:28

Nitric Oxide Signaling Pathway

Nitric oxide (NO), an inorganic gas, acts as a potent second messenger in most animal and plant tissues. NO diffuses out of the cells that produce it and enters the neighboring cells to generate a downstream response. NO synthase (NOS) catalyzes NO production by the deamination of the amino acid arginine. There are three isoforms of NOS. Endothelial cells have endothelial NOS (eNOS), nerve and muscle cells have neuronal NOS (nNOS), and macrophages produce inducible NOS (iNOS) upon exposure to...
Botulism01:22

Botulism

Botulism is a life-threatening neuroparalytic condition caused by botulinum neurotoxin, which is produced by the bacterium Clostridium botulinum, a Gram-positive, spore-forming, obligate anaerobe.In adults, the toxin enters the body in different ways: in foodborne botulism, the preformed toxin is absorbed in the intestine. In wound botulism, spores grow in injured tissue and release the toxin into the blood. Infant botulism differs mechanistically from adult forms. In infants, botulism commonly...
Indirect-Acting Cholinergic Agonists: Pharmacological Actions01:30

Indirect-Acting Cholinergic Agonists: Pharmacological Actions

Indirect-acting cholinergic agonists, also known as anticholinesterases, exert their pharmacological effects by enhancing cholinergic transmission in various body parts, including the neuromuscular junction, autonomic cholinergic synapses, and the brain.
At the neuromuscular junction, these agents work by inhibiting the breakdown of acetylcholine, allowing it to remain bound to the receptor and bind to nearby receptors. This process leads to repetitive firing of the endplate, causing muscle...